Plasmacytoid dendritic cell leukemia in children

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 5, 2009, Pages 339-343

  Hama, Asahito ^a   Kudo, Kazuko ^a,b   Itzel, Bustos Villalobos ^a   Muramatsu, Hideki ^a   Nishio, Nobuhiro ^a   Yoshida, Nao ^a   Takahashi, Yoshiyuki ^a   Yagasaki, Hiroshi ^a   Ito, Masafumi ^c   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Acute leukemia; CD4+ CD56+hematodermic neoplasm; Children; Plasmacytoid dendritic cell

Indexed keywords

ARABINOSIDE; BIOLOGICAL MARKER; BLOOD DENDRITIC CELL ANTIGEN 2; CD123 ANTIGEN; CD2 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTARABINE; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; MITOXANTRONE; TACROLIMUS; UNCLASSIFIED DRUG; CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ARTICLE; BLAST CELL; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER REGRESSION; CASE REPORT; CHILD; CLINICAL FEATURE; DERMIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOID CELL; MALE; PLASMACYTOID DENDRITIC CELL LEUKEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; SKIN BIOPSY; SUBCUTANEOUS NODULE; ACUTE DISEASE; BIOPSY; DENDRITIC CELL; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; SKIN TUMOR; T LYMPHOCYTE; TUMOR RECURRENCE;

ACUTE DISEASE; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; CHILD, PRESCHOOL; DENDRITIC CELLS; DERMIS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; MALE; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 66149143597     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31819b7215     Document Type: Article

References (18)

1. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994;47:278-282.
2. Brody JP, Allen S, Schulman P, et al. Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinico-pathologic studies including virologic and in vitro culture with inducing agents. Cancer. 1995;75:2474-2483.
3. + "lymphoma": report of two cases and review of the literature. Am J Clin Pathol. 1998; 110:478-488.
4. + agranular natural killer cell lymphoma of the skin. Am J Dermatopathol. 1998;20:513-517.
5. + lymphomas belong to the myelomonocytic lineage? J Invest Dermatol. 1998;111:1242-1244.
6. + cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol. 1999;23:137-146.
7. + blastic natural killer leukemia/lymphoma. Ann Hematol. 2001;80:228-231.
8. Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99: 1556-1563.
9. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
10. Rossi JG, Felice MS, Bernasconi AR, et al. Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome. Leuk Lymphoma. 2006;47: 715-725.
11. Shimada A, Taki T, Tabuchi K, et al. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood. 2006;107:1806-1809.
12. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97:3210-3217.
13. + lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88: 941-955.
14. +/ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica. 2006;91:143-144.
15. + malignancy and how should it be treated? Bone Marrow Transplant. 2003;32:637-646.
16. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037-6046.
17. Chaperot L, Perrot I, Jacob MC, et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol. 2004;34:418-426.
18. Sackmann-Muriel F, Felice MS, Zubizarreta PA, et al. Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM'90 protocol: lack of improvement in high-risk group. Leuk Res. 1999;23:331-340.